Barinthus Biotherapeutics Plc ADR (BRNS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2024 | 12-2023 | 12-2022 | 12-2021 | 12-2020 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 112,400 | 142,090 | 194,385 | 214,054 | 43,266 |
| Receivables | 7,139 | 4,908 | 10,388 | 6,249 | 3,226 |
| TOTAL | $125,742 | $156,905 | $213,041 | $226,765 | $47,901 |
| Non-Current Assets | |||||
| PPE Net | 7,373 | 11,821 | 7,957 | 1,829 | 629 |
| Intangibles | 21,947 | 37,317 | 40,478 | 44,060 | 0 |
| Other Non-Current Assets | 5,265 | 8,463 | 8,729 | 8,061 | 2,136 |
| TOTAL | $34,585 | $57,601 | $57,164 | $53,950 | $2,765 |
| Total Assets | $160,327 | $214,506 | $270,205 | $280,715 | $50,666 |
| Liabilities | |||||
| Current Liabilities | |||||
| Short Term Debt | N/A | N/A | N/A | 159 | N/A |
| Accounts payable and accrued liabilities | 2,474 | 1,601 | 3,748 | 2,419 | 4,667 |
| Accrued Expenses | 9,525 | 9,212 | 8,061 | 7,875 | 2,537 |
| TOTAL | $15,657 | $12,598 | $12,242 | $11,158 | $7,641 |
| Non-Current Liabilities | |||||
| Deferred Revenues | 1,738 | N/A | N/A | 182 | 245 |
| Other Non-Current Liabilities | 14,206 | 14,439 | 11,037 | 9,158 | 80,164 |
| TOTAL | $14,535 | $14,913 | $14,762 | $16,995 | $79,937 |
| Total Liabilities | $30,192 | $27,511 | $27,004 | $28,153 | $87,578 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 40,339 | 38,921 | 38,339 | 37,191 | N/A |
| Common Shares | 87 | 87 | 95 | 95 | 0 |
| Retained earnings | -237,664 | -176,590 | -103,243 | -108,585 | -57,720 |
| Other shareholders' equity | -25,762 | -23,104 | -33,155 | -8,051 | -852 |
| TOTAL | $130,135 | $186,995 | $243,201 | $252,562 | $-36,912 |
| Total Liabilities And Equity | $160,327 | $214,506 | $270,205 | $280,715 | $50,666 |